19 November 2021. Thailand Chulalongkorn University’s Centre of Excellence in Vaccine Research and Development expects to register its mRNA Covid-19 vaccine, known as ChulaCov-19, in the middle of next year. ChulaCov-19 is about to enter its third phase of human trials with jabs scheduled to be administered early next year to March.https://www.bangkokpost.com/thailand/general/2217851/thai-vaccine-to-enter-third-phase-of-trials